Anthropic Opens Bay Area Biology Wet Lab
Analysis based on 33 articles · First reported Sep 18, 2026 · Last updated Sep 18, 2026
The lab opening signals Anthropic's deeper push into life sciences, potentially accelerating AI-driven drug discovery and pressuring traditional pharma R&D models while raising competitive stakes for rivals like Alphabet's Isomorphic Labs. Investor attention centers on Anthropic's IPO prospects and the commercial potential of its biotech partnerships, though near-term revenue impact remains uncertain given the early-stage nature of the research.
Anthropic has quietly established a wet lab in the San Francisco Bay Area to conduct physical biology experiments, moving beyond computer-based in silico research into hands-on drug science. The lab's existence was confirmed by Eric Kauderer-Abrams, Anthropic's head of life sciences, in a Reuters interview, though a spokesperson clarified the facility is not specifically for drug discovery. The effort targets diseases that traditional pharmaceutical companies find financially unattractive, with Anthropic aiming to use its Claude AI to direct robotic systems in experiments with limited human intervention. Anthropic has built out its life sciences operations through the launch of Claude Science, a research workbench connecting to more than 60 scientific databases, the addition of Novartis CEO Shar Narasimhan to its board, and the acquisition of startup Coefficient Bio for about $400 million in stock. The company has also struck a collaboration with Novo Nordisk, reached an arrangement giving Bristol Myers Squibb staff access to Claude, and supplies AI services to Roche's F. Hoffmann-La Roche — Genentech. Anthropic says it is not running clinical trials and is not competing with pharma companies that bring drugs to market. The move comes amid Anthropic's warnings about AI risks, including potential biological weapons use, and as it prepares for a potentially $2 trillion IPO.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard